Hypercontractile phenotype at rest in chronic coronary syndromes predicts impaired functional reserve and increased mortality
ESC Heart Failure · 04.07.2026 · 13 (4)
DOI: 10.1093/eschf/xvag151 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift ESC Heart Failure, online erschienen am 06.06.2026. Verfasst von Quirino Ciampi und 40 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Fatebenefratelli Hospital, Viale Principe di Napoli, 12, Benevento I-82100, Italy. Hauptthemen laut MEDLINE: Stroke Volume, Ventricular Function, Left, Myocardial Contraction, Rest. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Società Italiana di Ecocardiografia e Cardiovascular Imaging, Regione Campania.
Abstract (Originalsprache)
Introduction
Transthoracic echocardiography (TTE) identifies a hypercontractile phenotype (HP) in chronic coronary syndromes (CCS), characterized by elevated resting left ventricular (LV) elastance (force = systolic blood pressure/end-systolic volume). To evaluate the prognostic significance and functional correlates of HP.
Methods
In a prospective multicentre study, 10 677 patients with CCS underwent resting TTE to assess LV ejection fraction (EF), stroke volume, and force by quantitative volumetric echocardiography. All patients were followed for the endpoint of all-cause mortality. In a subset of 5834 patients, stress echocardiography (exercise or dobutamine) was performed for LV contractile reserve and heart rate reserve.
Results
Patients were stratified into Force quintiles (Q1–Q5). Patients with hypercontractile phenotype exhibited lower stroke volume at rest (Q5 = 34.8 ± 12.3 vs Q1–Q4 = 57.4 ± 19.1 mL; P < .01) and higher EF at rest (Q5 = 64.8 ± 6.9% vs Q1–Q4 = 58.1 ± 8.7%, P < .01). During a median follow-up of 24 months (interquartile range = 12–40 months), 509 deaths occurred. The exposure-adjusted death rate was lowest in Q3 (3.53–4.51 mmHg/mL; 1.03 per 100 person/years) and higher in Q1 (≤2.62 mmHg/mL, 2.88), Q2 (2.63–3.52 mmHg/mL, 1.86), Q4 (4.52–6.11 mmHg/mL, 1.56), and Q5 (HP, >6.11 mmHg/mL; 1.88; P < .0001 vs Q1 and Q3). Multivariable analysis identified HP (Q5; HR 1.531 vs Q3, 95% CI 1.116–2.099; P = .006) and EF (HR 0.963, 95% CI 0.953–0.972; P < .0001) as independent predictors of death. During exercise or dobutamine stress, HP showed reduced LV contractile reserve (ΔEF: Q5 = 4.3 ± 9.4% vs Q1–Q4 = 7.0 ± 9.3%; P < .001) and blunted heart rate reserve (Q5 = 1.77 ± 0.33 vs Q1–Q4 = 1.85 ± 0.39; P < .01). All patients with force-based LV contractile reserve >4.1 (present in 185, 3.2% of the population) survived.
Conclusion
Patients with CCS with HP assessed by resting TTE demonstrate higher mortality and multilayered functional impairment, including reduced LV contractile and chronotropic reserves. Hypercontractile phenotype improved the prediction of mortality by EF. A ‘stronger’ heart is, in fact, functionally and prognostically weaker.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Fatebenefratelli Hospital, Viale Principe di Napoli, 12, Benevento I-82100, Italy.
- Department of Cardiovascular Ultrasound and Non-Invasive Cardiology, Sichuan Provincial People's Hospital, Chengdu, China.
- Cardiology Department, and Aesculapius Medical Center San Luca Hospital, Lucca, Italy.
- Cardiosurgery Department, St.Petersburg State University, Saint Petersburg, Russian Federation.
- Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
- Cardiodiagnosticos, Investigaciones Medicas, Buenos Aires, Argentina.
ORCID-Profile: Quirino Ciampi, Lauro Cortigiani, Angela Zagatina, Ratnasari Padang, Hector R Villarraga, Tamara Ryabova, Hugo Rodriguez-Zanella, Nicola Gaibazzi, Mauro Pepi
Förderung
- Società Italiana di Ecocardiografia e Cardiovascular Imaging
- Regione Campania
Zitieren
APA
Ciampi, Q., Wang, Y., Cortigiani, L., Zagatina, A., Padang, R., Kane, G. C., Villarraga, H. R., Arruda-Olson, A. M., Kalinina, E., Lowenstein, J., Arbucci, R., Lowenstein Haber, D. M., Marconi, S., Celutkiene, J., Boshchenko, A., Ryabova, T., Rodriguez-Zanella, H., Bursi, F., Wierzbowska-Drabik, K., …, & Picano, E. (2026). Hypercontractile phenotype at rest in chronic coronary syndromes predicts impaired functional reserve and increased mortality. ESC Heart Failure, 13(4). https://doi.org/10.1093/eschf/xvag151
Vancouver
Ciampi Q, Wang Y, Cortigiani L, Zagatina A, Padang R, Kane GC, et al. Hypercontractile phenotype at rest in chronic coronary syndromes predicts impaired functional reserve and increased mortality. ESC Heart Failure. 2026;13(4). doi:10.1093/eschf/xvag151
BibTeX
@article{Ciampi2026,
author = {Ciampi, Quirino and Wang, Yi and Cortigiani, Lauro and Zagatina, Angela and Padang, Ratnasari and Kane, Garvan C and Villarraga, Hector R and Arruda-Olson, Adelaide M and Kalinina, Elena and Lowenstein, Jorge and Arbucci, Rosina and Lowenstein Haber, Diego M and Marconi, Sofia and Celutkiene, Jelena and Boshchenko, Alla and Ryabova, Tamara and Rodriguez-Zanella, Hugo and Bursi, Francesca and Wierzbowska-Drabik, Karina and Kasprzak, Jaroslaw D and Merli, Elisa and Djordjevic-Dikic, Ana and Amor, Miguel and Haberka, Maciej and Saad, Ariel and Safarova, Ayten and Timofeeva, Tatiana and Peteiro Vazquez, Jesus and Rigo, Fausto and Nikolic, Aleksandra and Ostojic, Miodrag and Gaibazzi, Nicola and Kovacevic-Preradovic, Tamara and Cerracchio, Emma and Tripepi, Giovanni Luigi and Yin, Lixue and Villari, Bruno and Pepi, Mauro and Carerj, Scipione and Pellikka, Patricia A and Picano, Eugenio},
title = {Hypercontractile phenotype at rest in chronic coronary syndromes predicts impaired functional reserve and increased mortality},
journal = {ESC Heart Failure},
year = {2026},
volume = {13},
number = {4},
doi = {10.1093/eschf/xvag151}
}
EUVIMED